Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michela Roberto
Clinical Outcome of Third-Line Pazopanib in a Patient With Metastatic Renal Cell Carcinoma
Case Reports in Oncological Medicine
Oncology
Correction To: Exploring the Molecular Insights of Concurrent Composite Mucoepidermoid Carcinoma and Papillary Thyroid Carcinoma
Endocrine
Related publications
Pazopanib-Induced Liver Toxicity in Metastatic Renal Cell Carcinoma (mRCC) Patients: Impact of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety and Patient Outcome
Clinical Genitourinary Cancer
Oncology
Urology
Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Predictors of Long-Term Response With Pazopanib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Efficacy of Vertebral Cryoablation and Immunotherapy in a Patient With Metastatic Renal Cell Carcinoma: A Case Report
Journal of Medical Case Reports
Medicine
Angiogenesis Genotyping in the Selection of First-Line Treatment With Either Sunitinib or Pazopanib for Advanced Renal Cell Carcinoma
Oncotarget
Oncology
COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Oncologist
Cancer Research
Medicine
Oncology
